Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease

Chin Med J (Engl). 2018 Aug 20;131(16):1894-1897. doi: 10.4103/0366-6999.238133.

Authors

Han-Rong Feng¹, Chao Zhang¹, Song-Min Ying¹

Affiliation

¹ Department of Pharmacology & Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.

No abstract available

Keywords: Biologic Therapies; Chronic Obstructive Pulmonary Disease; Efficacy and Safety.

Publication types

Editorial

MeSH terms

Air Pollution
Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Lung / drug effects
Lung / metabolism
Models, Biological
Parenchymal Tissue / drug effects
Parenchymal Tissue / metabolism
Phosphodiesterase 4 Inhibitors / therapeutic use
Pulmonary Disease, Chronic Obstructive / drug therapy*
Pulmonary Disease, Chronic Obstructive / metabolism
World Health Organization

Substances

Antibodies, Monoclonal, Humanized
Phosphodiesterase 4 Inhibitors
benralizumab
mepolizumab